a University of Louisville School of Medicine, Louisville; Department of Behavioral Science, University of Kentucky College of Medicine, Lexington; and Veterans Administration Medical Center, Louisville, Kentucky
Feasibility and Acceptance of a Telehealth Intervention to Promote Symptom Management during Treatment for Head and Neck Cancer
Barbara A. Head PhD, RN, CHPN, ACSW
, a,
, Cynthia Keeney RN, MSNa, Jamie L. Studts PhDa, Mamdouh Khayata, medical student, Jeffrey Bumpous MDa and Mark Pfeifer MDa
Received 21 September 2010;
accepted 25 November 2010.
Available online 13 February 2011.
Patients undergoing treatment for head and neck cancers have a myriad of distressing symptoms and treatment side effects which significantly alter communication and lower quality of life. Telehealth technology has demonstrated promise in improving patient–provider communication by delivering supportive educational content and guidance to patients in their homes. A telehealth intervention using a simple telemessaging device was developed to provide daily education, guidance, and encouragement for patients undergoing initial treatment of head and neck cancer. The goal of this article is to report the feasibility and acceptance of the intervention using both quantitative and qualitative measures. No eligible patients declined participation based on technology issues. Participants completed the intervention for over 86% of the expected days of use. Direct nursing contact was seldom needed during the study period. Satisfaction with the technology and the intervention was very high. In this study a telehealth intervention was shown to be feasible, well accepted, and regularly used by patients experiencing extreme symptom burden and declining quality of life as a result of aggressive treatment for head and neck cancer.
Treatment for head and neck cancer is most often a rigorous regimen of combination therapies, producing a multitude of distressing symptoms and side effects. While it is nearly impossible to circumvent the physical and psychosocial insults caused by such treatment, some interventions directed toward educating and supporting patients during active treatment have met with success.[1], [2], [3] and [4] Conversely, other efforts have demonstrated little impact[5] and [6] or have been poorly received,
7> more Treatment-Related Side Effects articles
The Journal of Supportive Oncology
Focused on symptom and side-effect management, communication issues, and end-of-life care for patients with cancer.
For past issues, click here »
| Jun 1 - 5 Chicago, IL | American Society of Clinical Oncology (ASCO): Annual Meeting |
| Jun 14 - 17 Amsterdam, | European Hematology Association (EHA): Annual Congress |
| Jun 18 - 21 Lake Tahoe, NV | American Association for Cancer Research (AACR): Pancreatic Cancer: Progress and Challenges |
| Jun 20 - 22 Milan, | European Institute of Oncology (IEO): 14th Milan Breast Cancer Conference |
| Jun 25 - 26 London, | Teenage Cancer Trust (TCT): International Conference |
| Jun 27 - 30 Barcelona, | European Society for Medical Oncology (ESMO) Conference: World Congress on Gastrointestinal Cancer |
| Jun 27 - 30 Boston, MA | American Association for Cancer Research (AACR): Chemical Systems Biology |
| Jun 28 - 30 New York, NY | Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO): International Symposium |
| Jun 28 - 29 Paris, | WIN 2012 Symposium |
| Jul 7 - 10 Barcelona, | 22nd Biennial Congress of the European Association for Cancer Research |